We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+8.51%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$342M
AUM Growth
+$89.9M
Cap. Flow
+$78.3M
Cap. Flow %
22.9%
Top 10 Hldgs %
35.24%
Holding
113
New
44
Increased
16
Reduced
11
Closed
37

Top Buys

Rank Stock Value
1
XRAY icon
Dentsply Sirona
XRAY
+$9.51M
2
DXCM icon
DexCom
DXCM
+$8.48M
3
AGN
Allergan plc
AGN
+$8.14M
4
CNC icon
Centene
CNC
+$6.89M
5
INCY icon
Incyte
INCY
+$6.33M

Top Sells

Rank Stock Value
1
LH icon
Labcorp
LH
+$10M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$8.72M
3
CLVS
Clovis Oncology, Inc.
CLVS
+$6.55M
4
NXTM
NxStage Medical Inc.
NXTM
+$5.56M
5
QGENF
QIAGEN NV
QGENF
+$5.26M

Sector Composition

Rank Sector Weight
1 Healthcare 49.95%
2 Industrials 2.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$771B
$25.1M 7.35%
+100,000
New +$24.7M
PFE icon
2
CALL
Pfizer
PFE
$143B
$17.9M 5.22%
+527,000
New +$16.9M
BSX icon
3
Boston Scientific
BSX
$68.4B
$11.4M 3.33%
390,000
-30,546
-7% -$844K
LIVN icon
4
LivaNova
LIVN
$4.47B
$10.8M 3.16%
154,273
+14,271
+10% +$904K
ICUI icon
5
ICU Medical
ICUI
$4.16B
$10.7M 3.13%
57,500
+12,500
+28% +$2.18M
MRK icon
6
Merck
MRK
$322B
$9.9M 2.9%
161,989
+25,749
+19% +$1.56M
XRAY icon
7
Dentsply Sirona
XRAY
$2.84B
$9.57M 2.8%
+160,000
New +$9.51M
BAX icon
8
Baxter International
BAX
$12.8B
$8.47M 2.48%
135,000
+10,000
+8% +$618K
BAX icon
9
PUT
Baxter International
BAX
$12.8B
$8.47M 2.48%
+135,000
New +$8.34M
XLV icon
10
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$42.9B
$8.17M 2.39%
+100,000
New +$8.03M
IVC
11
DELISTED
Invacare Corporation
IVC
$7.88M 2.3%
500,000
-5,000
-1% -$71.4K
CNC icon
12
Centene
CNC
$30.5B
$7.74M 2.27%
+160,000
New +$6.89M
ATHN
13
DELISTED
Athenahealth, Inc.
ATHN
$7.44M 2.18%
59,800
+16,800
+39% +$2.31M
AGN
14
DELISTED
Allergan plc
AGN
$7.17M 2.1%
+35,000
New +$8.14M
BMY icon
15
CALL
Bristol-Myers Squibb
BMY
$129B
$6.37M 1.87%
+100,000
New +$5.84M
ESRX
16
DELISTED
Express Scripts Holding Company
ESRX
$6.33M 1.85%
100,000
-74,700
-43% -$4.64M
XENT
17
DELISTED
Intersect ENT, Inc
XENT
$6.23M 1.82%
200,000
+2,502
+1% +$74.1K
BIO icon
18
Bio-Rad Laboratories Class A
BIO
$8.76B
$6.22M 1.82%
28,000
+5,180
+23% +$1.17M
IWM icon
19
PUT
iShares Russell 2000 ETF
IWM
$79.1B
$5.93M 1.73%
+40,000
New +$5.63M
DXCM icon
20
DexCom
DXCM
$29B
$5.87M 1.72%
+480,000
New +$8.48M
INCY icon
21
Incyte
INCY
$25.8B
$5.84M 1.71%
+50,000
New +$6.33M
INCY icon
22
PUT
Incyte
INCY
$25.8B
$5.84M 1.71%
+50,000
New +$6.33M
EVHC
23
DELISTED
Envision Healthcare Holdings Inc
EVHC
$5.54M 1.62%
123,192
-64,008
-34% -$3.41M
WBA
24
CALL
DELISTED
Walgreens Boots Alliance
WBA
$5.41M 1.58%
+70,000
New +$5.61M
PEN icon
25
Penumbra
PEN
$12.6B
$5.38M 1.57%
59,579
+9,579
+19% +$825K
1
2 3 4 5

Similar funds

GMP
Great Mountain Partners New Haven, Connecticut $15.1M AUM 92.9% 1-Year Est. Return
BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
ONGA
O'Neil Global Advisors Los Angeles, California $14.4M AUM 220.73% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
CVV
Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SRA
Summit Rock Advisors New York $16M AUM
SR
Swiss Re Zurich, Switzerland $16.4M AUM

Pura Vida Investments's Q3 2017 Portfolio in Review

As of Q3 2017, Pura Vida Investments held 113 positions worth $342M, up 36% from $252M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Pura Vida Investments deployed $78.3M of net new capital in Q3 2017, opening 44 new positions and adding to 16 existing holdings. Its largest new stake was Dentsply Sirona: 160,000 shares worth $9.57M.

By sector, the portfolio is most concentrated in Healthcare at 50% of assets, down from 66% a quarter earlier, followed by Industrials.

On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $8.72M trimmed.

  • Pura Vida Investments's largest Q3 2017 buy was Dentsply Sirona: 160,000 shares worth $9.57M.
  • Pura Vida Investments added most to Athenahealth, Inc. in Q3 2017, an estimated $2.31M increase.
  • Pura Vida Investments's biggest Q3 2017 reduction was Alexion Pharmaceuticals, cutting an estimated $8.72M.
  • Pura Vida Investments fully exited Labcorp in Q3 2017, selling an estimated $10M.
  • Pura Vida Investments's ten largest holdings make up 35% of its $342M portfolio in Q3 2017.
  • Pura Vida Investments opened 44 new positions and closed 37 in Q3 2017.
  • Pura Vida Investments's portfolio value rose 36% quarter-over-quarter to $342M.

Based on Pura Vida Investments's 13F filing for Q3 2017, filed 14 Nov 2017.